Recently, Huang et al. developed an IL-7-loaded oncolytic Ad (oAD-IL7) and combined it with B7-H3-specific CAR T-cells to treat orthotopically glioblastoma-grafted mice. The gene discussed is IL7; the disease is glioblastoma.